Skip to Main Content

Author Details

Jean-Simon Diallo
Ottawa Hospital Research Institute, University of Ottawa
2006
83
30
PMIDPaper TitleJournal TitlePublished Year
36632686Combining povidone-iodine with vancomycin can be beneficial in reducing early biofilm formation of methicillin-resistant Staphylococcus aureus and methicillin-sensitive S. aureus on titanium surface.J Biomed Mater Res B Appl Biomater2023
37735876Optimal delivery of RNA interference by viral vectors for cancer therapy.Mol Ther2023
37822719A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection.Mol Ther Methods Clin Dev2023
37766429Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVο51 oncolytic virotherapy.Mol Ther2023
37153626Syngeneic mouse model of human HER2+ metastatic breast cancer for the evaluation of trastuzumab emtansine combined with oncolytic rhabdovirus.Front Immunol2023
37242495Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy.Pharmaceuticals (Basel)2023
36849805Safety and efficacy of autologous cell vaccines in solid tumors: a systematic review and meta-analysis of randomized control trials.Sci Rep2023
36713447CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX.Front Immunol2023
34687845Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection.Mol Ther2022
35740500A New Functional Screening Platform Identifies Colistin Sulfate as an Enhancer of Natural Killer Cell Cytotoxicity.Cancers (Basel)2022
35572196Dependency of EGFR activation in vanadium-based sensitization to oncolytic virotherapy.Mol Ther Oncolytics2022
35393414Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy.Nat Commun2022
35526097Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen.Mol Ther2022
36405739Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer.Front Immunol2022
36532027Vanadyl sulfate-enhanced oncolytic virus immunotherapy mediates the antitumor immune response by upregulating the secretion of pro-inflammatory cytokines and chemokines.Front Immunol2022
35104497Robust envelope exchange platform for oncolytic measles virus.J Virol Methods2022
33963789Safety and efficacy of autologous whole cell vaccines in hematologic malignancies: A systematic review and meta-analysis.Hematol Oncol2021
33706157SARS-CoV-2 S1 NanoBiT: A nanoluciferase complementation-based biosensor to rapidly probe SARS-CoV-2 receptor recognition.Biosens Bioelectron2021
33668756Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction.Int J Mol Sci2021
33614913Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models.Mol Ther Oncolytics2021
33555379Personalized oncology and BRAF<sup>K601N</sup> melanoma: model development, drug discovery, and clinical correlation.J Cancer Res Clin Oncol2021
33526607Immunotherapy for sarcomas: new frontiers and unveiled opportunities.J Immunother Cancer2021
33578036Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry.Mol Ther2021
34658235Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern.ACS Infect Dis2021
32518209Safety and efficacy of autologous tumour cell vaccines as a cancer therapeutic to treat solid tumours and haematological malignancies: a meta-analysis protocol for two systematic reviews.BMJ Open2020
33209979Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer Immunotherapy.Mol Ther Oncolytics2020
32872641Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization.Membranes (Basel)2020
32444806The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergy.Commun Biol2020
30794777SnapShot: Cancer Immunotherapy with Oncolytic Viruses.Cell2019
31561058Development of a novel screening platform for the identification of small molecule inhibitors of human adenovirus.Virology2019
31209680Enhancement of oncolytic virotherapy by vanadium(V) dipicolinates.Biometals2019
31276026Assessing the Completeness of Reporting in Preclinical Oncolytic Virus Therapy Studies.Mol Ther Oncolytics2019
29298865Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy.Sci Transl Med2018
30152676Oncolytic Viruses on Drugs: Achieving Higher Therapeutic Efficacy.ACS Infect Dis2018
29900060Transforming the prostatic tumor microenvironment with oncolytic virotherapy.Oncoimmunology2018
30138450Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis.PLoS Pathog2018
30538968Development and applications of oncolytic Maraba virus vaccines.Oncolytic Virother2018
29459853Does Treatment Order Matter? Investigating the Ability of Bacteriophage to Augment Antibiotic Activity against <i>Staphylococcus aureus</i> Biofilms.Front Microbiol2018
29367345Dimethyl fumarate potentiates oncolytic virotherapy through NF-κB inhibition.Sci Transl Med2018
29175158Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds.Mol Ther2018
28912369Customized Viral Immunotherapy for HPV-Associated Cancer.Cancer Immunol Res2017
28568891Oncolytic Maraba Virus MG1 as a Treatment for Sarcoma.Int J Cancer2017
27226390First-in-class small molecule potentiators of cancer virotherapy.Sci Rep2016
27614781Single-particle characterization of oncolytic vaccinia virus by flow virometry.Vaccine2016
27503504Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment.Breast Cancer Res2016
27119116Oncolytic vesicular stomatitis virus expressing interferon-γ has enhanced therapeutic activity.Mol Ther Oncolytics2016
25231172Clonal variation in interferon response determines the outcome of oncolytic virotherapy in mouse CT26 colon carcinoma model.Gene Ther2015
28741515Oncolytic Viruses: Exploiting Cancer's Deal with the Devil.Trends Cancer2015
26212250VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection.Cancer Cell2015
25894825Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity.Nat Med2015
  • 1 - 50 of 83

Recommended Authors

Manasi P Jogalekar
University of California San Francisco
Career Start Year 2017
Number of shared co-authors 0
Katie M Campbell
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2014
Number of shared co-authors 1
Kien Pham
Yale School of Public Health
Career Start Year 2012
Number of shared co-authors 0
Anusha Kalbasi
Stanford Cancer Institute, Stanford School of Medicine
Career Start Year 2010
Number of shared co-authors 2
Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 1
Alexandra Drakaki
David Geffen School of Medicine at university of california los angeles
Career Start Year 2009
Number of shared co-authors 2
John T Poirier
Laura and Isaac Perlmutter Cancer Center
Career Start Year 2007
Number of shared co-authors 2
James R Whittle
Walter and Eliza Hall Institute of Medical Research
Career Start Year 2006
Number of shared co-authors 0
Min Luo
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year 2006
Number of shared co-authors 0
Kris C Wood
Duke University
Career Start Year 2005
Number of shared co-authors 0
Pavlos Msaouel
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 1
Aleksandra A Pandyra
Hematology and Clinical Immunology, Heinrich-Heine University Dusseldorf
Career Start Year 2003
Number of shared co-authors 1
Elena Ivanova
Dana-Farber Cancer Institute
Career Start Year 2003
Number of shared co-authors 0
Marta M Alonso
CIMA-Universidad de Navarra
Career Start Year 2001
Number of shared co-authors 2
Michael J Gough
Earle A. Chiles Research Institute, Providence Cancer Institute
Career Start Year 1999
Number of shared co-authors 1
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
Renee C Ireton
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1997
Number of shared co-authors 0
Sunil J Advani
Moores Cancer Center, University of California San Diego
Career Start Year 1997
Number of shared co-authors 0
Iain A McNeish
Ovarian Cancer Action Research Centre, Imperial College London
Career Start Year 1996
Number of shared co-authors 2
Craig Gedye
Hunter Medical Research Institute, University of Newcastle
Career Start Year 1993
Number of shared co-authors 3
John W Barrett
University of Western Ontario
Career Start Year 1992
Number of shared co-authors 3
Zhiqiang An
Zhengzhou University
Career Start Year 1992
Number of shared co-authors 0
Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 0
Suresh Nair
Lehigh Valley Topper Cancer Institute
Career Start Year 1990
Number of shared co-authors 2
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 2
Juan Fueyo
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 4
Elizabeth M Jaffee
Convergence Institute, Johns Hopkins University
Career Start Year 1985
Number of shared co-authors 2
John T Schiller
David Geffen School of Medicine at university of california los angeles
Career Start Year 1984
Number of shared co-authors 1
Antonio Jimeno
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 0
George Yancey Gillespie
Heersink School of Medicine, The University of Alabama at Birmingham
Career Start Year 1970
Number of shared co-authors 1

Collaborators

John C Bell
Ottawa Hospital Research Institute
Co-authored papers 48
Carolina S Ilkow
Ottawa Hospital Research Institute
Co-authored papers 21
Zaid Taha
Ottawa Hospital Research Institute, University of Ottawa
Co-authored papers 17
Fred Saad
University of Montreal Health Center
Co-authored papers 12
Taha Azad
Ottawa Hospital Research Institute
Co-authored papers 12
Rebecca C Auer
The Ottawa Hospital Research Institute
Co-authored papers 12
Mathieu J F Crupi
Cancer Research Institute, Queen's University
Co-authored papers 11
Ragunath Singaravelu
Ottawa Hospital Research Institute
Co-authored papers 10
Adrian Pelin
University of Ottawa
Co-authored papers 9
Julia Petryk
Ottawa Hospital Research Institute
Co-authored papers 8
Dominic G Roy
Centre de Recherche du Centre Hospitalier de l'Universite de Montreal
Co-authored papers 7
Joanna Poutou
Ottawa Hospital Research Institute
Co-authored papers 7
Sarwat T Khan
Ottawa Hospital Research Institute
Co-authored papers 6
Xiao-Peng He
Ottawa Hospital Research Institute
Co-authored papers 5
Brian A Keller
The Ottawa Hospital/University of Ottawa
Co-authored papers 4
Christiano Tanese de Souza
Ottawa Hospital Research Institute, The Ottawa Hospital
Co-authored papers 4
Larissa A Pikor
Ottawa Hospital Research Institute
Co-authored papers 4
Abera Surendran
Ottawa Hospital Research Institute, The Ottawa Hospital
Co-authored papers 4
Victoria A Jennings
Leeds Institute of Medical Research at St James's, University of Leeds
Co-authored papers 3
Marie-??ve Wedge
Ottawa Hospital Research Institute
Co-authored papers 2
Almohanad A Alkayyal
College of Applied Medical Sciences, University of Tabuk
Co-authored papers 2
Meaghan Boileau
Ottawa Hospital Research Institute
Co-authored papers 2
Fuan Wang
Zhongnan Hospital of Wuhan University
Co-authored papers 2
Avijit Chatterjee
The Ottawa Hospital
Co-authored papers 2
Anna Dvorkin-Gheva
McMaster University
Co-authored papers 2
Michele Geoffrion
University of Ottawa Heart Institute
Co-authored papers 1
Katey J Rayner
University of Ottawa
Co-authored papers 1
Jonathan Kimmelman
McGill University
Co-authored papers 1
Mohsen Hooshyar
Department of Biology and Ottawa Institute of Systems Biology, Carleton University
Co-authored papers 1
Emily E F Brown
Ottawa Hospital Research Institute
Co-authored papers 1
Release 1.2